Leap Therapeutics (LPTX) Misses Q3 EPS by 44c

Leap Therapeutics (NASDAQ: LPTX) reported Q3 EPS of ($0.44).

For earnings history and earnings-related data on Leap Therapeutics (LPTX) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
• EagleOne Metals closes $225,199 non-brokered private placement